Additionally, genomic recombination can create FGFR1 fusion proteins, which are considered important oncogenic drivers in tumours like gastrointestinal stromal tumour (GIST), glioblastoma, breast cancer, bladder urothelial carcinoma or non-small cell lung cancer (NSCLC) [7]. Here, FGFR1 is linked to glioblastoma.